(Q36377733)

13 August 2017

Ethical use of antiretroviral resources for HIV prevention in resource poor settings (English)

1 reference

13 August 2017

0 references

anti-retroviral agent

0 references

prevention of HIV/AIDS

0 references

Stuart Rennie

1

0 references

publication date

31 May 2013

1 reference

13 August 2017

1 reference

13 August 2017

13

1 reference

13 August 2017

2

1 reference

13 August 2017

79-86

1 reference

HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Preexposure prophylaxis for HIV infection among African women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Given financial constraints, it would be unethical to divert antiretroviral drugs from treatment to prevention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Antiviral agents and HIV prevention: controversies, conflicts, and consensus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Prevention of HIV-1 infection with early antiretroviral therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forward

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Ethical challenges in long-term funding for HIV/AIDS.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Critical choices in financing the response to the global HIV/AIDS pandemic.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Barriers to access to antiretroviral treatment in developing countries: a review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Pre-exposure prophylaxis for HIV infection: what if it works?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Risk compensation: the Achilles' heel of innovations in HIV prevention?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Approaches to rationing antiretroviral treatment: ethical and equity implications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FDEWB.12022

Ethical allocation of preexposure HIV prophylaxis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4681503

Remedicalizing an epidemic: from HIV treatment as prevention to HIV treatment is prevention

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23724978

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/DEWB.12022

1 reference

13 August 2017

1 reference

PMC publication ID

4681503

13 August 2017

PubMed publication ID

23724978

1 reference

PMC publication ID

4681503